ArticleRheumatology (Oxford, England)2020

A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.

Laura S van Dam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.